Drug
PF-04991532
PF-04991532 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)
Phase Distribution
Ph phase_1
6
100%
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
6(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 16 (100.0%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_1
A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes
NCT01469065
completedphase_1
Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532
NCT01369602
completedphase_1
Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532
NCT01469481
completedphase_1
A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532
NCT01369277
completedphase_1
Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes
NCT01129258
Clinical Trials (6)
Showing 6 of 6 trials
NCT01469065Phase 1
A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes
NCT01369602Phase 1
Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532
NCT01469481Phase 1
Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532
NCT01369277Phase 1
A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532
NCT01129258Phase 1
Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes
NCT01102673Phase 1
Single Dose Study of PF-04991532 in Healthy Subjects
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6